| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |